Brief: Marinus Pharmaceuticals Announces European Commission Approval Of ZTALMY
31/07/2023 12:30
July 31 (Reuters) - Marinus Pharmaceuticals Inc
MRNS.O :
* MARINUS PHARMACEUTICALS ANNOUNCES EUROPEAN COMMISSION
APPROVAL
OF ZTALMY® (GANAXOLONE) FOR THE ADJUNCTIVE TREATMENT OF
EPILEPTIC SEIZURES ASSOCIATED WITH CDKL5 DEFICIENCY DISORDER
Source text for Eikon: ID:nBw3ghccYa
Further company coverage: MRNS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marinus Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP- Axsome Therapeutics, Ducommun, Vacasa
Brief: Immedica To Acquire Biopharmaceutical Company Marinus Pharmaceuticals
Marinus Pharmaceuticals Inc expected to post a loss of 41 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Appfolio, S&P Global, Uber
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group